Details of the Drug Combinations

General Information of This Drug (ID: DMWMPD4)

Drug Name
Vorinostat   DMWMPD4
Synonyms
NHNPODA; SAHA; SHH; Zolinza; Merck brand of Vorinostat; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; SAHA cpd; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat MSD; Vorinostat [USAN]; M344; MK0683; SKI390; WIN64652; MK-0683; SAHA, Suberoylanilide hydroxamic acid; SW-064652; Zolinza (TN); Vorinostat (JAN/USAN); N1-hydroxy-N8-phenyloctanediamide; Zolinza, MK-0683, SAHA; N'-hydroxy-N-phenyloctanediamide; N-Hydroxy-N'-phenyl octanediamide; N-Hyrdroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide; Vorinostat (HDAC inhibitor)
Indication
Disease Entry ICD 11 Status REF
Adult acute monocytic leukemia N.A. Approved [1]
Cutaneous T-cell lymphoma 2B01 Approved [2]
Ovarian neoplasm N.A. Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Primary cutaneous T-cell lymphoma N.A. Approved [1]
Adult glioblastoma N.A. Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

632 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Vorinostat DCX5P8Y 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
10-hydroxycamptothecin + Vorinostat DC4XU37 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Abacavir + Vorinostat DCM49F1 Abacavir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Acamprosate + Vorinostat DCSP0Q9 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Acetazolamide + Vorinostat DCMRWPF Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Acetohexamide + Vorinostat DCLF56W Acetohexamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Acetohydroxamic Acid + Vorinostat DCOO35B Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Alvespimycin hydrochloride + Vorinostat DCDKQZC Alvespimycin hydrochloride Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Amantadine + Vorinostat DCXDCJN Amantadine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Amiloride + Vorinostat DCZ5QLB Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Aminosalicylic acid + Vorinostat DC1QGX6 Aminosalicylic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Anamorelin + Vorinostat DCAK7MB Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Arfolitixorin + Vorinostat DCPHE52 Arfolitixorin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Armodafinil + Vorinostat DCCP74R Armodafinil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Artemisinin + Vorinostat DC9GJX6 Artemisinin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
AS-1949490 + Vorinostat DCAIXDL AS-1949490 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Azatadine + Vorinostat DC82CVB Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
AZD8330 + Vorinostat DCXDJW4 AZD8330 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Baclofen + Vorinostat DCKEW0J Baclofen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Bafilomycin A1 + Vorinostat DCLGX3G Bafilomycin A1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Bifemelane + Vorinostat DC36P96 Bifemelane DD2 (Cell Line: DD2) [3]
Bifemelane + Vorinostat DCB33AG Bifemelane Hepatoblastoma (Cell Line: HB3) [4]
BMS-754807 + Vorinostat DC1BFF0 BMS-754807 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Bortezomib + Vorinostat DCACME0 Bortezomib Adenocarcinoma (Cell Line: CAOV3) [3]
Bortezomib + Vorinostat DCF6N18 Bortezomib Adenocarcinoma (Cell Line: A427) [3]
Bortezomib + Vorinostat DC2LOPD Bortezomib Adenocarcinoma (Cell Line: NCIH2122) [3]
Bortezomib + Vorinostat DC2UQYS Bortezomib Adenocarcinoma (Cell Line: NCIH23) [3]
Bortezomib + Vorinostat DCXCL67 Bortezomib Adenocarcinoma (Cell Line: COLO320DM) [3]
Bortezomib + Vorinostat DC68Z2P Bortezomib Adenocarcinoma (Cell Line: DLD1) [3]
Bortezomib + Vorinostat DCUCH22 Bortezomib Adenocarcinoma (Cell Line: HCT116) [3]
Bortezomib + Vorinostat DC5WV1A Bortezomib Adenocarcinoma (Cell Line: SW-620) [3]
Bortezomib + Vorinostat DCY53QC Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Bortezomib + Vorinostat DCKC8LQ Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Bortezomib + Vorinostat DC7IVT5 Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Bortezomib + Vorinostat DC9RE1J Bortezomib Malignant melanoma (Cell Line: HT144) [3]
Bortezomib + Vorinostat DC9SL68 Bortezomib Malignant melanoma (Cell Line: RPMI7951) [3]
Bortezomib + Vorinostat DC7P8CQ Bortezomib Malignant melanoma (Cell Line: UACC62) [3]
Bortezomib + Vorinostat DCPE0YC Bortezomib Mesothelioma (Cell Line: MSTO) [3]
Bortezomib + Vorinostat DC4I2QW Bortezomib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Bortezomib + Vorinostat DCQ44HW Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Bortezomib + Vorinostat DCE4KV4 Bortezomib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Bortezomib + Vorinostat DCRZZSW Bortezomib Carcinoma (Cell Line: OV90) [5]
Bortezomib + Vorinostat DCVZZIX Bortezomib Carcinoma (Cell Line: EFM192B) [5]
Bortezomib + Vorinostat DC4NZYP Bortezomib Colon carcinoma (Cell Line: RKO) [5]
Bortezomib + Vorinostat DCKMBWA Bortezomib Rectal adenocarcinoma (Cell Line: SW837) [5]
Brincidofovir + Vorinostat DCLX6AM Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Bumetanide + Vorinostat DCUSWCS Bumetanide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Buspirone + Vorinostat DCWIH7O Buspirone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Busulfan + Vorinostat DCQQI17 Busulfan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Carfilzomib + Vorinostat DCOQ15A Carfilzomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Carglumic acid + Vorinostat DCGNYCZ Carglumic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cevimeline + Vorinostat DCHVIHY Cevimeline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Chlorambucil + Vorinostat DCBI42G Chlorambucil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ciprofibrate + Vorinostat DCIQ1ED Ciprofibrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Citalopram + Vorinostat DC33ED5 Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cytarabine + Vorinostat DCDNX5Y Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dactinomycin + Vorinostat DCLTK4I Dactinomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [4]
Dantrolene + Vorinostat DCXO1IV Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dasatinib + Vorinostat DCB0QV7 Dasatinib Adenocarcinoma (Cell Line: CAOV3) [3]
Dasatinib + Vorinostat DC99OCZ Dasatinib Adenocarcinoma (Cell Line: A427) [3]
Dasatinib + Vorinostat DC9RPUC Dasatinib Adenocarcinoma (Cell Line: NCIH520) [3]
Dasatinib + Vorinostat DC6OMNL Dasatinib Adenocarcinoma (Cell Line: DLD1) [3]
Dasatinib + Vorinostat DC90R6W Dasatinib Amelanotic melanoma (Cell Line: A2058) [3]
Dasatinib + Vorinostat DCFNNXN Dasatinib Germ cell tumour (Cell Line: PA1) [3]
Dasatinib + Vorinostat DCRLERA Dasatinib Malignant melanoma (Cell Line: A375) [3]
Dasatinib + Vorinostat DCL7511 Dasatinib Mesothelioma (Cell Line: MSTO) [3]
Dasatinib + Vorinostat DC435CN Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Dasatinib + Vorinostat DCRJVWA Dasatinib Breast carcinoma (Cell Line: KPL1) [5]
Dasatinib + Vorinostat DC9U3P4 Dasatinib Breast carcinoma (Cell Line: OCUBM) [5]
Dasatinib + Vorinostat DC8QL24 Dasatinib Colon carcinoma (Cell Line: RKO) [5]
Dasatinib + Vorinostat DCZ5KDO Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Dexmedetomidine + Vorinostat DCWEFBD Dexmedetomidine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dichlorphenamide + Vorinostat DC79PYM Dichlorphenamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dihydroergotamine + Vorinostat DCZL6US Dihydroergotamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Diphenidol + Vorinostat DC3IOSM Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dopamine + Vorinostat DCUYYUK Dopamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Enalaprilat + Vorinostat DCGTV46 Enalaprilat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Erlotinib + Vorinostat DCZQ1IB Erlotinib Adenocarcinoma (Cell Line: CAOV3) [3]
Erlotinib + Vorinostat DCROTWV Erlotinib Adenocarcinoma (Cell Line: A427) [3]
Erlotinib + Vorinostat DCTV7SH Erlotinib Adenocarcinoma (Cell Line: NCIH1650) [3]
Erlotinib + Vorinostat DCASJFL Erlotinib Adenocarcinoma (Cell Line: NCIH2122) [3]
Erlotinib + Vorinostat DC77GFM Erlotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Erlotinib + Vorinostat DC3LMA9 Erlotinib Adenocarcinoma (Cell Line: NCIH520) [3]
Erlotinib + Vorinostat DC91M0Q Erlotinib Adenocarcinoma (Cell Line: COLO320DM) [3]
Erlotinib + Vorinostat DCBYE56 Erlotinib Adenocarcinoma (Cell Line: DLD1) [3]
Erlotinib + Vorinostat DC3WG5W Erlotinib Adenocarcinoma (Cell Line: HCT116) [3]
Erlotinib + Vorinostat DCPZK4L Erlotinib Adenocarcinoma (Cell Line: HT29) [3]
Erlotinib + Vorinostat DCK3GX6 Erlotinib Adenocarcinoma (Cell Line: SW-620) [3]
Erlotinib + Vorinostat DC9PQ9X Erlotinib Amelanotic melanoma (Cell Line: A2058) [3]
Erlotinib + Vorinostat DCHN8GM Erlotinib Germ cell tumour (Cell Line: PA1) [3]
Erlotinib + Vorinostat DCJZSUN Erlotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Erlotinib + Vorinostat DCCE5IO Erlotinib Malignant melanoma (Cell Line: A375) [3]
Erlotinib + Vorinostat DCR7GSG Erlotinib Malignant melanoma (Cell Line: HT144) [3]
Erlotinib + Vorinostat DCAHUD1 Erlotinib Malignant melanoma (Cell Line: RPMI7951) [3]
Erlotinib + Vorinostat DCGSJ0E Erlotinib Malignant melanoma (Cell Line: SKMEL30) [3]
Erlotinib + Vorinostat DCS9F2B Erlotinib Malignant melanoma (Cell Line: UACC62) [3]
Erlotinib + Vorinostat DCTKC4U Erlotinib Mesothelioma (Cell Line: MSTO) [3]
Erlotinib + Vorinostat DCI97RR Erlotinib Non small cell carcinoma (Cell Line: SKMES1) [3]
Erlotinib + Vorinostat DCNZ2LQ Erlotinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Erlotinib + Vorinostat DCLQJHW Erlotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Erlotinib + Vorinostat DC6KA8K Erlotinib Prostate carcinoma (Cell Line: LNCAP) [3]
Erlotinib + Vorinostat DCK7BON Erlotinib Prostate carcinoma (Cell Line: VCAP) [3]
Erlotinib + Vorinostat DCVICYB Erlotinib Breast carcinoma (Cell Line: KPL1) [5]
Erlotinib + Vorinostat DCAS83L Erlotinib Breast carcinoma (Cell Line: OCUBM) [5]
Erlotinib + Vorinostat DCMNB4G Erlotinib Carcinoma (Cell Line: OV90) [5]
Erlotinib + Vorinostat DC49T0S Erlotinib Carcinoma (Cell Line: EFM192B) [5]
Erlotinib + Vorinostat DCSL948 Erlotinib Carcinoma (Cell Line: MDAMB436) [5]
Erlotinib + Vorinostat DCUCT7E Erlotinib Colon adenocarcinoma (Cell Line: LOVO) [5]
Erlotinib + Vorinostat DC2IX4Q Erlotinib Colon carcinoma (Cell Line: RKO) [5]
Erlotinib + Vorinostat DC9XEIA Erlotinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Erlotinib + Vorinostat DC0MJS2 Erlotinib Rectal adenocarcinoma (Cell Line: SW837) [5]
Estramustine + Vorinostat DC5GRBC Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ethinyl estradiol + Vorinostat DC8PG55 Ethinyl estradiol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fibrates + Vorinostat DC67A8Z Fibrates Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Flavonoid derivative 1 + Vorinostat DC4AJE9 Flavonoid derivative 1 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fluorouracil + Vorinostat DC2FVX8 Fluorouracil Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Fluorouracil + Vorinostat DCF67C7 Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Fluorouracil + Vorinostat DCKAO70 Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Fluorouracil + Vorinostat DCRBV5T Fluorouracil Breast carcinoma (Cell Line: KPL1) [5]
Fluorouracil + Vorinostat DC5BBUS Fluorouracil Carcinoma (Cell Line: OV90) [5]
Fluorouracil + Vorinostat DCDPN2G Fluorouracil Colon adenocarcinoma (Cell Line: LOVO) [5]
Fluorouracil + Vorinostat DC0I5SA Fluorouracil Colon carcinoma (Cell Line: RKO) [5]
Fluorouracil + Vorinostat DCEMXZ5 Fluorouracil Rectal adenocarcinoma (Cell Line: SW837) [5]
Fluorouracil + Vorinostat DCW836T Fluorouracil Adenocarcinoma (Cell Line: CAOV3) [4]
Fluorouracil + Vorinostat DC2FSRF Fluorouracil Adenocarcinoma (Cell Line: A427) [4]
Fluorouracil + Vorinostat DC5QHGP Fluorouracil Adenocarcinoma (Cell Line: NCIH2122) [4]
Fluorouracil + Vorinostat DCV83WK Fluorouracil Adenocarcinoma (Cell Line: NCIH520) [4]
Fluorouracil + Vorinostat DCILVFP Fluorouracil Adenocarcinoma (Cell Line: NCIH23) [4]
Fluorouracil + Vorinostat DCEBINH Fluorouracil Adenocarcinoma (Cell Line: DLD1) [4]
Fluorouracil + Vorinostat DCKOLOP Fluorouracil Adenocarcinoma (Cell Line: HCT116) [4]
Fluorouracil + Vorinostat DCHJD2C Fluorouracil Adenocarcinoma (Cell Line: HT29) [4]
Fluorouracil + Vorinostat DCK4R7R Fluorouracil Germ cell tumour (Cell Line: PA1) [4]
Fluorouracil + Vorinostat DC1N0E8 Fluorouracil Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Fluorouracil + Vorinostat DC7KNJ5 Fluorouracil Malignant melanoma (Cell Line: A375) [4]
Fluorouracil + Vorinostat DCR7WDK Fluorouracil Malignant melanoma (Cell Line: RPMI7951) [4]
Fluorouracil + Vorinostat DCAUUXL Fluorouracil Malignant melanoma (Cell Line: SKMEL30) [4]
Fluorouracil + Vorinostat DCMZ78E Fluorouracil Malignant melanoma (Cell Line: UACC62) [4]
Fluorouracil + Vorinostat DCG7SM4 Fluorouracil Mesothelioma (Cell Line: MSTO) [4]
Fluorouracil + Vorinostat DCU7ZMB Fluorouracil Non small cell carcinoma (Cell Line: SKMES1) [4]
Fluorouracil + Vorinostat DC52G1F Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Fluorouracil + Vorinostat DCGD4J5 Fluorouracil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Fluorouracil + Vorinostat DC619NY Fluorouracil Prostate carcinoma (Cell Line: VCAP) [4]
Fomepizole + Vorinostat DCFR4OD Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Galantamine + Vorinostat DCR9UOH Galantamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Gefitinib + Vorinostat DCJJDEO Gefitinib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
GSK525762 + Vorinostat DCPEY3B GSK525762 Breast carcinoma (Cell Line: KPL1) [5]
GYKI-52466 + Vorinostat DCCKHM1 GYKI-52466 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Hydralazine + Vorinostat DCKDT4X Hydralazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Hyodeoxycholic acid + Vorinostat DCJ5QS6 Hyodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Idarubicin + Vorinostat DCLJMAS Idarubicin Adenocarcinoma (Cell Line: NCIH2122) [4]
Idarubicin + Vorinostat DC8BHW5 Idarubicin Amelanotic melanoma (Cell Line: A2058) [4]
Idarubicin + Vorinostat DCVIIHX Idarubicin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Idarubicin + Vorinostat DCABAXC Idarubicin Malignant melanoma (Cell Line: A375) [4]
Idarubicin + Vorinostat DC870WL Idarubicin Malignant melanoma (Cell Line: RPMI7951) [4]
Idarubicin + Vorinostat DC3FNKP Idarubicin Malignant melanoma (Cell Line: UACC62) [4]
Idarubicin + Vorinostat DCEFFRL Idarubicin Mesothelioma (Cell Line: MSTO) [4]
Idarubicin + Vorinostat DCIGQN8 Idarubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Imatinib + Vorinostat DCS2KSP Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Isoproterenol + Vorinostat DCY3RIH Isoproterenol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Isosorbide dinitrate + Vorinostat DCC2RPK Isosorbide dinitrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
IT-141 + Vorinostat DC72CUA IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
K-134 + Vorinostat DC6HZYE K-134 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lapatinib + Vorinostat DC1AOH0 Lapatinib Breast carcinoma (Cell Line: ZR751) [5]
Lapatinib + Vorinostat DCOGIEF Lapatinib Breast carcinoma (Cell Line: KPL1) [5]
Lapatinib + Vorinostat DC7YAUN Lapatinib Breast carcinoma (Cell Line: OCUBM) [5]
Lapatinib + Vorinostat DCN0EME Lapatinib Carcinoma (Cell Line: EFM192B) [5]
Lapatinib + Vorinostat DC256VK Lapatinib Colon carcinoma (Cell Line: RKO) [5]
Lapatinib + Vorinostat DC1Q0F2 Lapatinib Adenocarcinoma (Cell Line: CAOV3) [4]
Lapatinib + Vorinostat DCJ0SXH Lapatinib Adenocarcinoma (Cell Line: A427) [4]
Lapatinib + Vorinostat DCZVJHA Lapatinib Adenocarcinoma (Cell Line: NCIH1650) [4]
Lapatinib + Vorinostat DCVHK2C Lapatinib Adenocarcinoma (Cell Line: NCIH2122) [4]
Lapatinib + Vorinostat DCJ78S8 Lapatinib Adenocarcinoma (Cell Line: NCIH23) [4]
Lapatinib + Vorinostat DCU3ID6 Lapatinib Adenocarcinoma (Cell Line: DLD1) [4]
Lapatinib + Vorinostat DC1IGNI Lapatinib Amelanotic melanoma (Cell Line: A2058) [4]
Lapatinib + Vorinostat DCGUPWN Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Lapatinib + Vorinostat DCRP7OQ Lapatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Lapatinib + Vorinostat DC458L1 Lapatinib Malignant melanoma (Cell Line: RPMI7951) [4]
Lapatinib + Vorinostat DCYX2P1 Lapatinib Malignant melanoma (Cell Line: SKMEL30) [4]
Lapatinib + Vorinostat DC6CQ8P Lapatinib Non small cell carcinoma (Cell Line: SKMES1) [4]
Lapatinib + Vorinostat DCN3NXC Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Lapatinib + Vorinostat DCT8BQ2 Lapatinib Prostate carcinoma (Cell Line: VCAP) [4]
LEE011 + Vorinostat DCNZ7TA LEE011 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Levamisole + Vorinostat DCC2PTI Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lumefantrine + Vorinostat DC57VFR Lumefantrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
LY03004 + Vorinostat DC20H7P LY03004 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Maprotiline + Vorinostat DCMJ3QE Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Maraviroc + Vorinostat DC0IE4Q Maraviroc Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mebutamate + Vorinostat DCK4DB1 Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Metaxalone + Vorinostat DC90GFF Metaxalone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methylene blue + Vorinostat DC1F912 Methylene blue Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Miconazole + Vorinostat DCZV7JC Miconazole DD2 (Cell Line: DD2) [3]
Miglustat + Vorinostat DCQVPNQ Miglustat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
MK-1775 + Vorinostat DC2YOAN MK-1775 Adenocarcinoma (Cell Line: CAOV3) [3]
MK-1775 + Vorinostat DCFOEF8 MK-1775 Adenocarcinoma (Cell Line: NCIH2122) [3]
MK-1775 + Vorinostat DCA5L2F MK-1775 Adenocarcinoma (Cell Line: NCIH23) [3]
MK-1775 + Vorinostat DCLTDUS MK-1775 Adenocarcinoma (Cell Line: NCIH520) [3]
MK-1775 + Vorinostat DC5QXMU MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [3]
MK-1775 + Vorinostat DC38FI7 MK-1775 Adenocarcinoma (Cell Line: DLD1) [3]
MK-1775 + Vorinostat DCATNB5 MK-1775 Adenocarcinoma (Cell Line: HCT116) [3]
MK-1775 + Vorinostat DCUCXMF MK-1775 Adenocarcinoma (Cell Line: HT29) [3]
MK-1775 + Vorinostat DC550KZ MK-1775 Amelanotic melanoma (Cell Line: A2058) [3]
MK-1775 + Vorinostat DC2FGVX MK-1775 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
MK-1775 + Vorinostat DCK35VP MK-1775 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-1775 + Vorinostat DCINHCD MK-1775 Germ cell tumour (Cell Line: PA1) [3]
MK-1775 + Vorinostat DC2XHKH MK-1775 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
MK-1775 + Vorinostat DCP0V28 MK-1775 Malignant melanoma (Cell Line: A375) [3]
MK-1775 + Vorinostat DCNALVK MK-1775 Malignant melanoma (Cell Line: RPMI7951) [3]
MK-1775 + Vorinostat DCXER2J MK-1775 Malignant melanoma (Cell Line: SKMEL30) [3]
MK-1775 + Vorinostat DCMC327 MK-1775 Mesothelioma (Cell Line: MSTO) [3]
MK-1775 + Vorinostat DCKQQTA MK-1775 Non small cell carcinoma (Cell Line: SKMES1) [3]
MK-1775 + Vorinostat DCYHZFO MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
MK-1775 + Vorinostat DCI5C9V MK-1775 Prostate carcinoma (Cell Line: VCAP) [3]
MK-1775 + Vorinostat DCCVQIT MK-1775 Colon adenocarcinoma (Cell Line: LOVO) [5]
MK-1775 + Vorinostat DCUHNEO MK-1775 Colon carcinoma (Cell Line: RKO) [5]
MK-2206 + Vorinostat DCB8LB8 MK-2206 Adenocarcinoma (Cell Line: A427) [3]
MK-2206 + Vorinostat DCXN5UW MK-2206 Adenocarcinoma (Cell Line: NCIH1650) [3]
MK-2206 + Vorinostat DCPJORZ MK-2206 Adenocarcinoma (Cell Line: NCIH2122) [3]
MK-2206 + Vorinostat DCFFDYO MK-2206 Adenocarcinoma (Cell Line: COLO320DM) [3]
MK-2206 + Vorinostat DCPB6ZR MK-2206 Adenocarcinoma (Cell Line: HCT116) [3]
MK-2206 + Vorinostat DCYGDQ5 MK-2206 Adenocarcinoma (Cell Line: HT29) [3]
MK-2206 + Vorinostat DCFDNXE MK-2206 Amelanotic melanoma (Cell Line: A2058) [3]
MK-2206 + Vorinostat DCZD8K8 MK-2206 Germ cell tumour (Cell Line: PA1) [3]
MK-2206 + Vorinostat DCKIYP4 MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
MK-2206 + Vorinostat DCMKMM7 MK-2206 Malignant melanoma (Cell Line: RPMI7951) [3]
MK-2206 + Vorinostat DC06HPW MK-2206 Malignant melanoma (Cell Line: SKMEL30) [3]
MK-2206 + Vorinostat DCR89W6 MK-2206 Malignant melanoma (Cell Line: UACC62) [3]
MK-2206 + Vorinostat DCRURKU MK-2206 Mesothelioma (Cell Line: MSTO) [3]
MK-2206 + Vorinostat DCTZX79 MK-2206 Non small cell carcinoma (Cell Line: SKMES1) [3]
MK-2206 + Vorinostat DCS3RIL MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
MK-2206 + Vorinostat DCOEZPT MK-2206 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
MK-2206 + Vorinostat DC021WS MK-2206 Prostate carcinoma (Cell Line: VCAP) [3]
MK-2206 + Vorinostat DCL1JBR MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
MK-2206 + Vorinostat DCPFMBR MK-2206 Breast carcinoma (Cell Line: KPL1) [5]
MK-2206 + Vorinostat DCIC7RA MK-2206 Carcinoma (Cell Line: OV90) [5]
MK-2206 + Vorinostat DCU5WAS MK-2206 Carcinoma (Cell Line: MDAMB436) [5]
MK-2206 + Vorinostat DCBK977 MK-2206 Colon adenocarcinoma (Cell Line: LOVO) [5]
MK-2206 + Vorinostat DCRR4D9 MK-2206 Colon carcinoma (Cell Line: RKO) [5]
MK-2206 + Vorinostat DCTUGNN MK-2206 Invasive ductal carcinoma (Cell Line: T-47D) [5]
MK-2206 + Vorinostat DC3USAG MK-2206 Rectal adenocarcinoma (Cell Line: SW837) [5]
MK-4827 + Vorinostat DCS4G54 MK-4827 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-4827 + Vorinostat DC4CE3X MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
MK-4827 + Vorinostat DC46UW6 MK-4827 Breast carcinoma (Cell Line: KPL1) [5]
MK-4827 + Vorinostat DCGZ38Z MK-4827 Carcinoma (Cell Line: EFM192B) [5]
MK-4827 + Vorinostat DC9V27I MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [5]
MK-4827 + Vorinostat DC8SFSF MK-4827 Colon carcinoma (Cell Line: RKO) [5]
MK-4827 + Vorinostat DCDU05D MK-4827 Invasive ductal carcinoma (Cell Line: T-47D) [5]
MK-4827 + Vorinostat DC2KGL8 MK-4827 Adenocarcinoma (Cell Line: CAOV3) [4]
MK-4827 + Vorinostat DC2KWCJ MK-4827 Adenocarcinoma (Cell Line: OVCAR3) [4]
MK-4827 + Vorinostat DCXW6ZW MK-4827 Adenocarcinoma (Cell Line: A427) [4]
MK-4827 + Vorinostat DCAWLWZ MK-4827 Adenocarcinoma (Cell Line: NCIH1650) [4]
MK-4827 + Vorinostat DCC5MW7 MK-4827 Adenocarcinoma (Cell Line: NCIH2122) [4]
MK-4827 + Vorinostat DCLDAS5 MK-4827 Adenocarcinoma (Cell Line: NCIH520) [4]
MK-4827 + Vorinostat DC82E4Q MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [4]
MK-4827 + Vorinostat DC9WLZR MK-4827 Adenocarcinoma (Cell Line: DLD1) [4]
MK-4827 + Vorinostat DC973KC MK-4827 Adenocarcinoma (Cell Line: HCT116) [4]
MK-4827 + Vorinostat DCMP2NX MK-4827 Adenocarcinoma (Cell Line: HT29) [4]
MK-4827 + Vorinostat DCWOABF MK-4827 Adenocarcinoma (Cell Line: SW-620) [4]
MK-4827 + Vorinostat DCCVM9I MK-4827 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
MK-4827 + Vorinostat DCWBS26 MK-4827 Malignant melanoma (Cell Line: A375) [4]
MK-4827 + Vorinostat DCBTCDD MK-4827 Malignant melanoma (Cell Line: HT144) [4]
MK-4827 + Vorinostat DCGG9NF MK-4827 Malignant melanoma (Cell Line: RPMI7951) [4]
MK-4827 + Vorinostat DC2JYBE MK-4827 Malignant melanoma (Cell Line: SKMEL30) [4]
MK-4827 + Vorinostat DCO84UU MK-4827 Malignant melanoma (Cell Line: UACC62) [4]
MK-4827 + Vorinostat DC3HB5O MK-4827 Mesothelioma (Cell Line: MSTO) [4]
MK-4827 + Vorinostat DCY5P9Z MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [4]
MK-4827 + Vorinostat DC80YXF MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
MK-4827 + Vorinostat DC6V2DG MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
MK-4827 + Vorinostat DC7JVX4 MK-4827 Prostate carcinoma (Cell Line: VCAP) [4]
MK-5108 + Vorinostat DCR7ZQO MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-5108 + Vorinostat DC1G6XU MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
MK-5108 + Vorinostat DCGZH4N MK-5108 Carcinoma (Cell Line: EFM192B) [5]
MK-5108 + Vorinostat DCEY35Z MK-5108 Carcinoma (Cell Line: MDAMB436) [5]
MK-5108 + Vorinostat DC4Z7Z3 MK-5108 Colon adenocarcinoma (Cell Line: LOVO) [5]
MK-5108 + Vorinostat DCDZDKF MK-5108 Invasive ductal carcinoma (Cell Line: T-47D) [5]
MK-5108 + Vorinostat DCUXG7L MK-5108 Adenocarcinoma (Cell Line: CAOV3) [4]
MK-5108 + Vorinostat DCLQF33 MK-5108 Adenocarcinoma (Cell Line: DLD1) [4]
MK-5108 + Vorinostat DCREZHD MK-5108 Adenocarcinoma (Cell Line: SW-620) [4]
MK-5108 + Vorinostat DCFX8YB MK-5108 Amelanotic melanoma (Cell Line: A2058) [4]
MK-5108 + Vorinostat DCJGOYE MK-5108 Germ cell tumour (Cell Line: PA1) [4]
MK-5108 + Vorinostat DCG7Z2J MK-5108 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
MK-5108 + Vorinostat DC2OSVM MK-5108 Malignant melanoma (Cell Line: RPMI7951) [4]
MK-5108 + Vorinostat DCVZT9N MK-5108 Malignant melanoma (Cell Line: SKMEL30) [4]
MK-5108 + Vorinostat DCN0807 MK-5108 Malignant melanoma (Cell Line: UACC62) [4]
MK-5108 + Vorinostat DCONO8P MK-5108 Mesothelioma (Cell Line: MSTO) [4]
MK-5108 + Vorinostat DC48P5X MK-5108 Non small cell carcinoma (Cell Line: SKMES1) [4]
MK-5108 + Vorinostat DCSXGZM MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
MK-5108 + Vorinostat DCNQT6C MK-5108 Prostate carcinoma (Cell Line: VCAP) [4]
Niclosamide + Vorinostat DC2T8NS Niclosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nitisinone + Vorinostat DCKXBSV Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Norcisapride + Vorinostat DC2N825 Norcisapride Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Novobiocin + Vorinostat DCOCGB4 Novobiocin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
ONC201 + Vorinostat DCTYV52 ONC201 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Oxandrolone + Vorinostat DC6D35W Oxandrolone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pamidronate + Vorinostat DC8866Q Pamidronate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Paromomycin + Vorinostat DCAG6DK Paromomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pazopanib + Vorinostat DCMKVFI Pazopanib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pazopanib HCl + Vorinostat DC50Y6L Pazopanib HCl Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PD-0325901 + Vorinostat DCLVSII PD-0325901 Ewing sarcoma (Cell Line: TC-71) [3]
PD-0325901 + Vorinostat DCKKWU2 PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
PD-0325901 + Vorinostat DCPR3JG PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
PD-0325901 + Vorinostat DCMHLSU PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
PD-0325901 + Vorinostat DCRGZPJ PD-0325901 Breast carcinoma (Cell Line: KPL1) [5]
PD-0325901 + Vorinostat DC87UQ0 PD-0325901 Breast carcinoma (Cell Line: OCUBM) [5]
PD-0325901 + Vorinostat DC128K8 PD-0325901 Carcinoma (Cell Line: OV90) [5]
PD-0325901 + Vorinostat DCW66OZ PD-0325901 Colon carcinoma (Cell Line: RKO) [5]
PD-0325901 + Vorinostat DC0CIZE PD-0325901 Invasive ductal carcinoma (Cell Line: T-47D) [5]
PD-0325901 + Vorinostat DCSDKWT PD-0325901 Rectal adenocarcinoma (Cell Line: SW837) [5]
PD-0325901 + Vorinostat DCK6AU9 PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [4]
PD-0325901 + Vorinostat DCY0MJ5 PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [4]
PD-0325901 + Vorinostat DCHD19T PD-0325901 Adenocarcinoma (Cell Line: A427) [4]
PD-0325901 + Vorinostat DCZONCK PD-0325901 Adenocarcinoma (Cell Line: NCIH1650) [4]
PD-0325901 + Vorinostat DCWOGKM PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [4]
PD-0325901 + Vorinostat DC8H7BV PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [4]
PD-0325901 + Vorinostat DC4NGI9 PD-0325901 Adenocarcinoma (Cell Line: NCIH520) [4]
PD-0325901 + Vorinostat DCVUXPJ PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [4]
PD-0325901 + Vorinostat DC12CKB PD-0325901 Adenocarcinoma (Cell Line: DLD1) [4]
PD-0325901 + Vorinostat DCHOPIQ PD-0325901 Adenocarcinoma (Cell Line: HCT116) [4]
PD-0325901 + Vorinostat DCC3WC6 PD-0325901 Adenocarcinoma (Cell Line: HT29) [4]
PD-0325901 + Vorinostat DCPSPI8 PD-0325901 Adenocarcinoma (Cell Line: SW-620) [4]
PD-0325901 + Vorinostat DCZK2W6 PD-0325901 Amelanotic melanoma (Cell Line: A2058) [4]
PD-0325901 + Vorinostat DCBTV1O PD-0325901 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
PD-0325901 + Vorinostat DC7TOCT PD-0325901 Malignant melanoma (Cell Line: A375) [4]
PD-0325901 + Vorinostat DCMV03R PD-0325901 Malignant melanoma (Cell Line: HT144) [4]
PD-0325901 + Vorinostat DCRCHCE PD-0325901 Malignant melanoma (Cell Line: RPMI7951) [4]
PD-0325901 + Vorinostat DCE526N PD-0325901 Malignant melanoma (Cell Line: SKMEL30) [4]
PD-0325901 + Vorinostat DCIG20P PD-0325901 Mesothelioma (Cell Line: MSTO) [4]
PD-0325901 + Vorinostat DC1QEDH PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
PD-0325901 + Vorinostat DCD4ZT4 PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
PD-0325901 + Vorinostat DCOBK02 PD-0325901 Prostate carcinoma (Cell Line: LNCAP) [4]
PD-0325901 + Vorinostat DCRW4LT PD-0325901 Prostate carcinoma (Cell Line: VCAP) [4]
Pentamidine + Vorinostat DC525JH Pentamidine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Vorinostat DCRWT0I Pentostatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PFK-158 + Vorinostat DCBHLWF PFK-158 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PHA-739358 + Vorinostat DC8QRXW PHA-739358 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Phenprocoumon + Vorinostat DCUYIBX Phenprocoumon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Plinabulin + Vorinostat DC9ALM8 Plinabulin Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
PMID28460551-Compound-2 + Vorinostat DC3TRZ2 PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
PMID28460551-Compound-2 + Vorinostat DC7TOV4 PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
PMID28460551-Compound-2 + Vorinostat DCT9K83 PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
PMID28460551-Compound-2 + Vorinostat DCOFY89 PMID28460551-Compound-2 Breast carcinoma (Cell Line: ZR751) [5]
PMID28460551-Compound-2 + Vorinostat DCQFOLQ PMID28460551-Compound-2 Breast carcinoma (Cell Line: KPL1) [5]
PMID28460551-Compound-2 + Vorinostat DCWJ3OH PMID28460551-Compound-2 Breast carcinoma (Cell Line: OCUBM) [5]
PMID28460551-Compound-2 + Vorinostat DC4UCNN PMID28460551-Compound-2 Carcinoma (Cell Line: OV90) [5]
PMID28460551-Compound-2 + Vorinostat DCFTIYM PMID28460551-Compound-2 Carcinoma (Cell Line: EFM192B) [5]
PMID28460551-Compound-2 + Vorinostat DCAW2GI PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: LOVO) [5]
PMID28460551-Compound-2 + Vorinostat DCQTTOG PMID28460551-Compound-2 Colon carcinoma (Cell Line: RKO) [5]
PMID28460551-Compound-2 + Vorinostat DCTIMBB PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: T-47D) [5]
PMID28460551-Compound-2 + Vorinostat DCLFV1G PMID28460551-Compound-2 Rectal adenocarcinoma (Cell Line: SW837) [5]
PMID28460551-Compound-2 + Vorinostat DC3VCEE PMID28460551-Compound-2 Adenocarcinoma (Cell Line: OVCAR3) [4]
PMID28460551-Compound-2 + Vorinostat DC3F4IA PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH2122) [4]
PMID28460551-Compound-2 + Vorinostat DCG6B9T PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [4]
PMID28460551-Compound-2 + Vorinostat DCFGHI0 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: COLO320DM) [4]
PMID28460551-Compound-2 + Vorinostat DCBVUQ9 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DLD1) [4]
PMID28460551-Compound-2 + Vorinostat DC3E8R7 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCT116) [4]
PMID28460551-Compound-2 + Vorinostat DC09PJX PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HT29) [4]
PMID28460551-Compound-2 + Vorinostat DCJZEVI PMID28460551-Compound-2 Adenocarcinoma (Cell Line: SW-620) [4]
PMID28460551-Compound-2 + Vorinostat DCUN9IP PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [4]
PMID28460551-Compound-2 + Vorinostat DCHTWZ6 PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
PMID28460551-Compound-2 + Vorinostat DCLLQEW PMID28460551-Compound-2 Malignant melanoma (Cell Line: A375) [4]
PMID28460551-Compound-2 + Vorinostat DCUH97P PMID28460551-Compound-2 Malignant melanoma (Cell Line: HT144) [4]
PMID28460551-Compound-2 + Vorinostat DC1MLV2 PMID28460551-Compound-2 Malignant melanoma (Cell Line: RPMI7951) [4]
PMID28460551-Compound-2 + Vorinostat DCAV7GU PMID28460551-Compound-2 Malignant melanoma (Cell Line: SKMEL30) [4]
PMID28460551-Compound-2 + Vorinostat DC6TOK0 PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [4]
PMID28460551-Compound-2 + Vorinostat DCLJVMU PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [4]
PMID28460551-Compound-2 + Vorinostat DCT0G8H PMID28460551-Compound-2 Non small cell carcinoma (Cell Line: SKMES1) [4]
PMID28460551-Compound-2 + Vorinostat DCG38RJ PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
PMID28460551-Compound-2 + Vorinostat DCIS8M7 PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
PMID28460551-Compound-2 + Vorinostat DCQHHEE PMID28460551-Compound-2 Prostate carcinoma (Cell Line: VCAP) [4]
Pramipexole + Vorinostat DC6MLZY Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Procarbazine + Vorinostat DCIRVXF Procarbazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Quinine + Vorinostat DCG35G3 Quinine Hepatoblastoma (Cell Line: HB3) [3]
Ramelteon + Vorinostat DCQ5MLJ Ramelteon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ribavirin-TP + Vorinostat DCCJRBK Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Rifampin + Vorinostat DCZ6G1F Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Rufinamide + Vorinostat DC88BMD Rufinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
SB 228357 + Vorinostat DCQRTST SB 228357 Hepatoblastoma (Cell Line: HB3) [4]
SCH 727965 + Vorinostat DCPWG1I SCH 727965 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
SCH 727965 + Vorinostat DCKPV1A SCH 727965 Breast carcinoma (Cell Line: KPL1) [5]
SCH 727965 + Vorinostat DCCANFM SCH 727965 Colon carcinoma (Cell Line: RKO) [5]
SCH 727965 + Vorinostat DC1P1GU SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [4]
SCH 727965 + Vorinostat DC8AQD0 SCH 727965 Adenocarcinoma (Cell Line: A427) [4]
SCH 727965 + Vorinostat DCN5SZD SCH 727965 Adenocarcinoma (Cell Line: NCIH1650) [4]
SCH 727965 + Vorinostat DCF60S1 SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [4]
SCH 727965 + Vorinostat DCTW5RS SCH 727965 Adenocarcinoma (Cell Line: COLO320DM) [4]
SCH 727965 + Vorinostat DCAE0XS SCH 727965 Adenocarcinoma (Cell Line: HCT116) [4]
SCH 727965 + Vorinostat DCQGCWH SCH 727965 Adenocarcinoma (Cell Line: SW-620) [4]
SCH 727965 + Vorinostat DC7PHE7 SCH 727965 Amelanotic melanoma (Cell Line: A2058) [4]
SCH 727965 + Vorinostat DCU12K2 SCH 727965 Germ cell tumour (Cell Line: PA1) [4]
SCH 727965 + Vorinostat DC26REZ SCH 727965 Malignant melanoma (Cell Line: A375) [4]
SCH 727965 + Vorinostat DCCPEB2 SCH 727965 Malignant melanoma (Cell Line: RPMI7951) [4]
SCH 727965 + Vorinostat DC3EFXI SCH 727965 Malignant melanoma (Cell Line: SKMEL30) [4]
SCH 727965 + Vorinostat DCPXP0A SCH 727965 Mesothelioma (Cell Line: MSTO) [4]
SCH 727965 + Vorinostat DCTA3FY SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SCH 727965 + Vorinostat DCK2PVR SCH 727965 Prostate carcinoma (Cell Line: VCAP) [4]
Sertraline + Vorinostat DCDI2QR Sertraline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
SNX-2112 + Vorinostat DC2P2K0 SNX-2112 Adenocarcinoma (Cell Line: DLD1) [3]
SNX-2112 + Vorinostat DC38ERZ SNX-2112 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
SNX-2112 + Vorinostat DCU7ND2 SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
SNX-2112 + Vorinostat DCWB0RC SNX-2112 Breast carcinoma (Cell Line: OCUBM) [5]
SNX-2112 + Vorinostat DC2W81A SNX-2112 Colon carcinoma (Cell Line: RKO) [5]
SNX-2112 + Vorinostat DCF0Y2J SNX-2112 Invasive ductal carcinoma (Cell Line: T-47D) [5]
SNX-2112 + Vorinostat DCI70I0 SNX-2112 Rectal adenocarcinoma (Cell Line: SW837) [5]
SNX-2112 + Vorinostat DC0MWPH SNX-2112 Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + Vorinostat DCH8KKC SNX-2112 Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + Vorinostat DCGIK92 SNX-2112 Adenocarcinoma (Cell Line: NCIH1650) [4]
SNX-2112 + Vorinostat DC9RMD3 SNX-2112 Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + Vorinostat DCLNQ1K SNX-2112 Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + Vorinostat DCFH5R0 SNX-2112 Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + Vorinostat DC9LRDG SNX-2112 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + Vorinostat DCDU3FX SNX-2112 Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + Vorinostat DCAK19P SNX-2112 Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + Vorinostat DC6P74Q SNX-2112 Malignant melanoma (Cell Line: RPMI7951) [4]
SNX-2112 + Vorinostat DCWRB1T SNX-2112 Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + Vorinostat DCXWD0G SNX-2112 Mesothelioma (Cell Line: MSTO) [4]
SNX-2112 + Vorinostat DC1KZG4 SNX-2112 Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + Vorinostat DCZYVAG SNX-2112 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + Vorinostat DC2C9Z2 SNX-2112 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Sorafenib + Vorinostat DC22E23 Sorafenib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Spironolactone + Vorinostat DC3GGR7 Spironolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Sumatriptan + Vorinostat DCVY2BI Sumatriptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tacrine + Vorinostat DCSO9S4 Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Terameprocol + Vorinostat DCNZBCH Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Testolactone + Vorinostat DCT8VYY Testolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Testosterone + Vorinostat DCJKSZG Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tetracycline + Vorinostat DCS8494 Tetracycline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tolazoline + Vorinostat DC6KZT7 Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tolvaptan + Vorinostat DCOPUVE Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trifluoperazine + Vorinostat DCT4SO1 Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tropisetron + Vorinostat DCZWYWJ Tropisetron Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Valproic Acid + Vorinostat DCG4F3O Valproic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Verapamil + Vorinostat DCCE0KZ Verapamil DD2 (Cell Line: DD2) [4]
Vincristine + Vorinostat DCH0OXD Vincristine Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vorinostat + Meclofenamic acid DCG97F6 Meclofenamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Lefaxin DCKHQ49 Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Picoplatin DCBJINY Picoplatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Bepridil DC81YEJ Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Triiodothyronine DCCIHH7 Triiodothyronine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Clindamycin DC36ADU Clindamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Diethylcarbamazine DCYOD4H Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Ruxolitinib DCR76A1 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [3]
Vorinostat + Lumefantrine DC2WJRV Lumefantrine DD2 (Cell Line: DD2) [3]
Vorinostat + Lumefantrine DCISVDB Lumefantrine Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Kanamycin DCTMTZ3 Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Imipramine DCDHQWA Imipramine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Furazolidone DCKULRL Furazolidone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + T-3.5 DCA4M8G T-3.5 Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Chlorphenesin DC8MFUN Chlorphenesin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mephenytoin DCUNWAR Mephenytoin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + RTB101 DCUDC1L RTB101 Adenocarcinoma (Cell Line: CAOV3) [3]
Vorinostat + RTB101 DCHH9I7 RTB101 Adenocarcinoma (Cell Line: A427) [3]
Vorinostat + RTB101 DCLS7CU RTB101 Adenocarcinoma (Cell Line: NCIH1650) [3]
Vorinostat + RTB101 DCZJ68N RTB101 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vorinostat + RTB101 DCIXRI1 RTB101 Adenocarcinoma (Cell Line: NCIH23) [3]
Vorinostat + RTB101 DCSYHTX RTB101 Adenocarcinoma (Cell Line: NCIH520) [3]
Vorinostat + RTB101 DCSL0RP RTB101 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vorinostat + RTB101 DC7Y2WT RTB101 Adenocarcinoma (Cell Line: DLD1) [3]
Vorinostat + RTB101 DCFUPTT RTB101 Adenocarcinoma (Cell Line: HCT116) [3]
Vorinostat + RTB101 DC555F6 RTB101 Adenocarcinoma (Cell Line: HT29) [3]
Vorinostat + RTB101 DCAKTPQ RTB101 Adenocarcinoma (Cell Line: SW-620) [3]
Vorinostat + RTB101 DCR2YJN RTB101 Amelanotic melanoma (Cell Line: A2058) [3]
Vorinostat + RTB101 DCSI83N RTB101 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vorinostat + RTB101 DCIP34M RTB101 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vorinostat + RTB101 DCYZC05 RTB101 Malignant melanoma (Cell Line: A375) [3]
Vorinostat + RTB101 DCOJD80 RTB101 Malignant melanoma (Cell Line: HT144) [3]
Vorinostat + RTB101 DCNVPAF RTB101 Malignant melanoma (Cell Line: RPMI7951) [3]
Vorinostat + RTB101 DC7ORZ4 RTB101 Malignant melanoma (Cell Line: SKMEL30) [3]
Vorinostat + RTB101 DCT11NZ RTB101 Malignant melanoma (Cell Line: UACC62) [3]
Vorinostat + RTB101 DC1TKK3 RTB101 Mesothelioma (Cell Line: MSTO) [3]
Vorinostat + RTB101 DCIYBHD RTB101 Non small cell carcinoma (Cell Line: SKMES1) [3]
Vorinostat + RTB101 DCN1W7B RTB101 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vorinostat + RTB101 DC1FXLW RTB101 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vorinostat + RTB101 DCUPU3O RTB101 Prostate carcinoma (Cell Line: LNCAP) [3]
Vorinostat + RTB101 DCVDV78 RTB101 Prostate carcinoma (Cell Line: VCAP) [3]
Vorinostat + SCH-900776 DCPW82Q SCH-900776 Adenocarcinoma (Cell Line: CAOV3) [3]
Vorinostat + SCH-900776 DC2W6FY SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vorinostat + SCH-900776 DC1RCMZ SCH-900776 Adenocarcinoma (Cell Line: A427) [3]
Vorinostat + SCH-900776 DCTX1QX SCH-900776 Adenocarcinoma (Cell Line: NCIH1650) [3]
Vorinostat + SCH-900776 DC8V0B1 SCH-900776 Adenocarcinoma (Cell Line: NCIH520) [3]
Vorinostat + SCH-900776 DCRPD5O SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vorinostat + SCH-900776 DCA2TST SCH-900776 Adenocarcinoma (Cell Line: DLD1) [3]
Vorinostat + SCH-900776 DCWFQTN SCH-900776 Adenocarcinoma (Cell Line: HCT116) [3]
Vorinostat + SCH-900776 DCQE95X SCH-900776 Adenocarcinoma (Cell Line: HT29) [3]
Vorinostat + SCH-900776 DC820TV SCH-900776 Amelanotic melanoma (Cell Line: A2058) [3]
Vorinostat + SCH-900776 DCHNK6M SCH-900776 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vorinostat + SCH-900776 DCMWD7E SCH-900776 Malignant melanoma (Cell Line: A375) [3]
Vorinostat + SCH-900776 DCW4CCF SCH-900776 Malignant melanoma (Cell Line: HT144) [3]
Vorinostat + SCH-900776 DCIHE7C SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [3]
Vorinostat + SCH-900776 DCI75HV SCH-900776 Malignant melanoma (Cell Line: SKMEL30) [3]
Vorinostat + SCH-900776 DC02JQN SCH-900776 Mesothelioma (Cell Line: MSTO) [3]
Vorinostat + SCH-900776 DCJ6E0E SCH-900776 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vorinostat + SCH-900776 DCX2BLO SCH-900776 Prostate carcinoma (Cell Line: VCAP) [3]
Vorinostat + Sivelestat DC8VZKZ Sivelestat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Everolimus DCH3UBB Everolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Tranexamic acid DCSIZSB Tranexamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Thiolactomycin DCUYNMH Thiolactomycin Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Palonosetron DCH2RFE Palonosetron Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Metyrosine DCAJQPT Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Efavirenz DC0V6ID Efavirenz Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + TAK-733 DCMKVV9 TAK-733 Glioblastoma (Cell Line: JHH-136) [3]
Vorinostat + Amodiaquine DCOO77T Amodiaquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Itraconazole DCKKWN1 Itraconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Emetine DCTJJSI Emetine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Cinacalcet DCJH9VU Cinacalcet Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Doxapram DCUN9TE Doxapram Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Metformin DCL0CS3 Metformin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Docetaxel DCNZETV Docetaxel Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + ETHISTERONE DC902TK ETHISTERONE Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Methoxsalen DCXSFRH Methoxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Sulfinpyrazone DC1KXKQ Sulfinpyrazone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Ginsenoside Rb1 DC0APMM Ginsenoside Rb1 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Daidzin DC6IY47 Daidzin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Phensuximide DCV171R Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + VR-776 DC92EGU VR-776 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Armodafinil DCTM9KD Armodafinil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mecamylamine DC0N726 Mecamylamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mitomycin DC1VT2H Mitomycin Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
Vorinostat + Clopidogrel DCJ95TB Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Diphenidol DCGYUHX Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Pentamidine DCRGT27 Pentamidine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Tolazoline DCB7L51 Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Eflornithine DCCYHT2 Eflornithine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + OSI-027 DC8QV3H OSI-027 Glioblastoma (Cell Line: JHH-136) [3]
Vorinostat + Trazodone DCHDM8B Trazodone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Flavopiridol DCQE8MP Flavopiridol Glioblastoma (Cell Line: JHH-136) [3]
Vorinostat + Ibutilide DCOPD18 Ibutilide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + GINKGOLIDE A DCZ0UNT GINKGOLIDE A Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Diazoxide DCIK5I5 Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Fenoprofen DC3VIRN Fenoprofen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Entacapone DC3HAPB Entacapone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Ridaforolimus DCOOD1L Ridaforolimus Adenocarcinoma (Cell Line: CAOV3) [3]
Vorinostat + Ridaforolimus DCX32I8 Ridaforolimus Adenocarcinoma (Cell Line: NCIH2122) [3]
Vorinostat + Ridaforolimus DCQOVL7 Ridaforolimus Adenocarcinoma (Cell Line: NCIH520) [3]
Vorinostat + Ridaforolimus DCL0FQE Ridaforolimus Adenocarcinoma (Cell Line: DLD1) [3]
Vorinostat + Ridaforolimus DCOEWXJ Ridaforolimus Adenocarcinoma (Cell Line: HCT116) [3]
Vorinostat + Ridaforolimus DC6S4Q9 Ridaforolimus Amelanotic melanoma (Cell Line: A2058) [3]
Vorinostat + Ridaforolimus DCKAX17 Ridaforolimus Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vorinostat + Ridaforolimus DC552QL Ridaforolimus Germ cell tumour (Cell Line: PA1) [3]
Vorinostat + Ridaforolimus DCQX0J6 Ridaforolimus Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vorinostat + Ridaforolimus DC11BUH Ridaforolimus Malignant melanoma (Cell Line: A375) [3]
Vorinostat + Ridaforolimus DCC79U2 Ridaforolimus Malignant melanoma (Cell Line: HT144) [3]
Vorinostat + Ridaforolimus DCFDTTV Ridaforolimus Malignant melanoma (Cell Line: RPMI7951) [3]
Vorinostat + Ridaforolimus DC3L5CB Ridaforolimus Malignant melanoma (Cell Line: UACC62) [3]
Vorinostat + Ridaforolimus DCNAYYU Ridaforolimus Mesothelioma (Cell Line: MSTO) [3]
Vorinostat + Ridaforolimus DC3TSDM Ridaforolimus Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vorinostat + Ridaforolimus DC545GZ Ridaforolimus Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vorinostat + Ridaforolimus DCQFE2D Ridaforolimus Prostate carcinoma (Cell Line: VCAP) [3]
Vorinostat + Benserazide DCAYKUM Benserazide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Idarubicin DCYVVIZ Idarubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Idarubicin DC01ROC Idarubicin Glioblastoma? (Cell Line: T98G) [3]
Vorinostat + Methocarbamol DCMEOHK Methocarbamol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Epothilone B DC9U8MY Epothilone B Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Probenecid DCVIZOY Probenecid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Atenolol DC9I2EG Atenolol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Acamprosate DCM78W5 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mesalazine DCEIVAF Mesalazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Moricizine DCA6731 Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Olanzapine DCM217X Olanzapine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Clascoterone DCE2UVH Clascoterone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Trimethobenzamide DCOANG2 Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Oxyphenbutazone DCJQAN5 Oxyphenbutazone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Teriflunomide DC2YGUE Teriflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Ethambutol DCOV7LO Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Fenretinide DCV3BT9 Fenretinide Glioblastoma (Cell Line: JHH-136) [3]
Vorinostat + Theophylline DCBSXYM Theophylline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Brincidofovir DCHM4YV Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Sorafenib DCVF73F Sorafenib Adenocarcinoma (Cell Line: CAOV3) [3]
Vorinostat + Sorafenib DCLW1PF Sorafenib Adenocarcinoma (Cell Line: A427) [3]
Vorinostat + Sorafenib DCZEEM7 Sorafenib Adenocarcinoma (Cell Line: NCIH23) [3]
Vorinostat + Sorafenib DCUVTUA Sorafenib Adenocarcinoma (Cell Line: NCIH520) [3]
Vorinostat + Sorafenib DCONX1V Sorafenib Adenocarcinoma (Cell Line: DLD1) [3]
Vorinostat + Sorafenib DCLPY5N Sorafenib Adenocarcinoma (Cell Line: HCT116) [3]
Vorinostat + Sorafenib DCMWJOK Sorafenib Adenocarcinoma (Cell Line: SW-620) [3]
Vorinostat + Sorafenib DCICK1X Sorafenib Amelanotic melanoma (Cell Line: A2058) [3]
Vorinostat + Sorafenib DCCZW7G Sorafenib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vorinostat + Sorafenib DCU1ZUQ Sorafenib Germ cell tumour (Cell Line: PA1) [3]
Vorinostat + Sorafenib DCWSQVK Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vorinostat + Sorafenib DCL6RJ0 Sorafenib Malignant melanoma (Cell Line: A375) [3]
Vorinostat + Sorafenib DC2TJG1 Sorafenib Malignant melanoma (Cell Line: HT144) [3]
Vorinostat + Sorafenib DCL7YF6 Sorafenib Malignant melanoma (Cell Line: RPMI7951) [3]
Vorinostat + Sorafenib DCZS2WJ Sorafenib Malignant melanoma (Cell Line: UACC62) [3]
Vorinostat + Sorafenib DCUQKM3 Sorafenib Mesothelioma (Cell Line: MSTO) [3]
Vorinostat + Sorafenib DCYNPD1 Sorafenib Non small cell carcinoma (Cell Line: SKMES1) [3]
Vorinostat + Sorafenib DCKCA7V Sorafenib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vorinostat + Sorafenib DCOFHUY Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vorinostat + Sorafenib DCNNDQ9 Sorafenib Prostate carcinoma (Cell Line: VCAP) [3]
Vorinostat + Desoxycorticosterone pivalate DC9T3ZW Desoxycorticosterone pivalate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Chloroquine DC202LF Chloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Asenapine DC4996Y Asenapine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Quinine DCUFWGL Quinine DD2 (Cell Line: DD2) [3]
Vorinostat + Quinine DCLZHNN Quinine Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + MK-4815 DCTISXK MK-4815 DD2 (Cell Line: DD2) [3]
Vorinostat + MK-4815 DC305TY MK-4815 Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Endoxifen DC760E6 Endoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mycophenolic acid DCIAF7U Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Pyronaridine DC5Z4BH Pyronaridine Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Cisatracurium DC5BVRR Cisatracurium Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mefloquine DCXRP99 Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Mefloquine DCTPO49 Mefloquine Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + JTC-801 DCSREJ2 JTC-801 Hepatoblastoma (Cell Line: HB3) [3]
Vorinostat + Pizotyline DCE33CL Pizotyline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Lacosamide DCO8UTY Lacosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Doxorubicin DCLKZUN Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Iloprost DCRG9OA Iloprost Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Zileuton DCEH6YX Zileuton Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Olmesartan medoxomil DC5C1TX Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + PMID28870136-Compound-43 DCFEJUW PMID28870136-Compound-43 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Cerivastatin DCJTYPF Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Hydroxychloroquine DC0EVEW Hydroxychloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Atovaquone DCSPEJ3 Atovaquone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Albendazole DC21Z53 Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Ibrutinib DCGA4T4 Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
Vorinostat + Nitrosoglutathione DCLYWF6 Nitrosoglutathione Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Etomidate DCU0A7M Etomidate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Cilostazol DC84FD2 Cilostazol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + RTB101 DC0MVM5 RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vorinostat + RTB101 DC00MOZ RTB101 Breast carcinoma (Cell Line: KPL1) [5]
Vorinostat + RTB101 DC4UG94 RTB101 Carcinoma (Cell Line: EFM192B) [5]
Vorinostat + RTB101 DCJ73XG RTB101 Colon carcinoma (Cell Line: RKO) [5]
Vorinostat + RTB101 DCC6D78 RTB101 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vorinostat + RTB101 DCBTML2 RTB101 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vorinostat + SCH-900776 DCT0KO1 SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vorinostat + SCH-900776 DCRFVOR SCH-900776 Breast carcinoma (Cell Line: OCUBM) [5]
Vorinostat + SCH-900776 DCUQR9S SCH-900776 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vorinostat + Ridaforolimus DC076PV Ridaforolimus Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vorinostat + Ridaforolimus DCHG02S Ridaforolimus Breast carcinoma (Cell Line: KPL1) [5]
Vorinostat + Ridaforolimus DCNG9WV Ridaforolimus Colon adenocarcinoma (Cell Line: LOVO) [5]
Vorinostat + Ridaforolimus DCK6GAX Ridaforolimus Colon carcinoma (Cell Line: RKO) [5]
Vorinostat + Ridaforolimus DCNXBZX Ridaforolimus Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vorinostat + Ridaforolimus DC2HYD7 Ridaforolimus Rectal adenocarcinoma (Cell Line: SW837) [5]
Vorinostat + Sorafenib DCFZD6I Sorafenib Carcinoma (Cell Line: OV90) [5]
Vorinostat + Sorafenib DCLHFAG Sorafenib Colon carcinoma (Cell Line: RKO) [5]
Zaleplon + Vorinostat DCUF7L8 Zaleplon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 632 DrugCom(s)
32 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Azacitidine + Vorinostat DC8Z65K Azacitidine Adult Nasal Type Extranodal NK/T-Cell Lymphoma [6]
Azacitidine + Vorinostat DCL4UYT Azacitidine Acute Erythroid Leukemia [7]
Bexarotene + Vorinostat DC3INZG Bexarotene Lymphoma [8]
Bortezomib + Vorinostat DC9QK1T Bortezomib Multiple Myeloma [9]
Capecitabine + Vorinostat DC0RQKZ Capecitabine Unspecified Adult Solid Tumor, Protocol Specific [10]
Capecitabine + Vorinostat DCUC1UP Capecitabine Paranasal Sinus Squamous Cell Carcinoma [11]
Cladribine + Vorinostat DCKSYUJ Cladribine Recurrent B-Cell Non-Hodgkin Lymphoma [12]
Decitabine + Vorinostat DCPUNFY Decitabine Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities [13]
Docetaxel + Vorinostat DCKGEJR Docetaxel Non-Small-Cell Lung Carcinoma [14]
Erlotinib + Vorinostat DCEPOR6 Erlotinib Carcinoma, Non-Small-Cell Lung [15]
Etoposide + Vorinostat DCWKWJ0 Etoposide Accelerated Phase Chronic Myelogenous Leukemia [16]
Everolimus + Vorinostat DCV85IB Everolimus Advanced Cancer [17]
Flavopiridol + Vorinostat DCCZNIU Flavopiridol Blastic Phase Chronic Myelogenous Leukemia [18]
Flavopiridol + Vorinostat DCH0OLQ Flavopiridol Unspecified Adult Solid Tumor, Protocol Specific [19]
Idarubicin + Vorinostat DCQ0CWF Idarubicin Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome [20]
Isotretinoin + Vorinostat DCWAGZ7 Isotretinoin Recurrent Renal Cell Cancer [21]
Isotretinoin + Vorinostat DCZ8O53 Isotretinoin Childhood Acute Promyelocytic Leukemia (M3) [22]
Lapatinib + Vorinostat DCBGJ59 Lapatinib Breast Cancer [23]
Lenalidomide + Vorinostat DC3WOYY Lenalidomide Multiple Myeloma [24]
Lenalidomide + Vorinostat DCJ64A7 Lenalidomide Adult Nasal Type Extranodal NK/T-cell Lymphoma [25]
Mycophenolic acid + Vorinostat DCFHBQS Mycophenolic acid Hematologic Malignancies [26]
Nicotinamide + Vorinostat DCUGVJL Nicotinamide Hodgkin's Disease [27]
Olaparib + Vorinostat DC37MKG Olaparib Breast Cancer Metastatic [28]
Paclitaxel + Vorinostat DCL4C98 Paclitaxel Male Breast Cancer [29]
Paclitaxel + Vorinostat DCTOJ2D Paclitaxel Stage IIIA Non-small Cell Lung Cancer [30]
Pazopanib + Vorinostat DCY9U4L Pazopanib Advanced Cancer [31]
Ridaforolimus + Vorinostat DCL3CEH Ridaforolimus Lymphoma [32]
Temozolomide + Vorinostat DC8OAFH Temozolomide Adult Glioblastoma [33]
Temozolomide + Vorinostat DC9PREA Temozolomide Childhood Atypical Teratoid/Rhabdoid Tumor [34]
Temsirolimus + Vorinostat DC2E6JA Temsirolimus Advanced Cancer [17]
Vorinostat + Hydroxychloroquine DCS2EYR Hydroxychloroquine Malignant Solid Tumour [35]
Methotrexate + Vorinostat DCMHPS9 Methotrexate Graft vs Host Disease [36]
------------------------------------------------------------------------------------
⏷ Show the Full List of 32 DrugCom(s)

References

1 Vorinostat FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6852).
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6 ClinicalTrials.gov (NCT00336063) Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
7 ClinicalTrials.gov (NCT00392353) Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
8 ClinicalTrials.gov (NCT00127101) An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
9 ClinicalTrials.gov (NCT00111813) Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
10 ClinicalTrials.gov (NCT00121277) Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
11 ClinicalTrials.gov (NCT01267240) Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
12 ClinicalTrials.gov (NCT00764517) Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma
13 ClinicalTrials.gov (NCT00275080) Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
14 ClinicalTrials.gov (NCT00565227) Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
15 ClinicalTrials.gov (NCT00251589) A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)
16 ClinicalTrials.gov (NCT00357305) Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
17 ClinicalTrials.gov (NCT01087554) Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
18 ClinicalTrials.gov (NCT00278330) Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
19 ClinicalTrials.gov (NCT00324480) Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
20 ClinicalTrials.gov (NCT00331513) Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
21 ClinicalTrials.gov (NCT00324740) Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
22 ClinicalTrials.gov (NCT00217412) Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
23 ClinicalTrials.gov (NCT01118975) GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
24 ClinicalTrials.gov (NCT00729118) Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
25 ClinicalTrials.gov (NCT01116154) Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
26 ClinicalTrials.gov (NCT00810602) Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
27 ClinicalTrials.gov (NCT00691210) Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
28 ClinicalTrials.gov (NCT03742245) Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
29 ClinicalTrials.gov (NCT00368875) Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
30 ClinicalTrials.gov (NCT00662311) Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery
31 ClinicalTrials.gov (NCT01339871) Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
32 ClinicalTrials.gov (NCT01169532) Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
33 ClinicalTrials.gov (NCT01342757) Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
34 ClinicalTrials.gov (NCT01076530) Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
35 ClinicalTrials.gov (NCT01023737) Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
36 ClinicalTrials.gov (NCT01790568) Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant